Back to News
Market Impact: 0.25
Centene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline Deepens
Source: Nasdaq
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Centene reaffirmed its 2026 adjusted diluted EPS guidance of more than $4.80 at the Deutsche Bank Healthcare Summit. CEO Sarah London indicated that company performance through the first two periods referenced was supporting the outlook, although the provided article text is incomplete.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
CNC0.35
More News
- All eyes on PTC earnings amid pending Schneider acquisition
- Jefferies downgrades Haleon stock rating on margin concerns
- Dow Jones Forecast: Futures Surge as Democrats Take Congress, AI Stocks Lag
- Which sectors will benefit most and face pressure after Democratic sweep?
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh